Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Compare the incidence of severe clinical exacerbations in the treatment of ABPA, between a strategy with a maintenance treatment and a conventional strategy without antifungal maintenance therapy.
Epistemonikos ID: f84a3a6979a6ae59b98a73a77cc7aa66d31ffc7d
First added on: May 12, 2024